Summary We studied 83 lung cancer patients and 129 controls for the EcoRI polymorphism of the L-myc gene. No association was found between the L-myc RFLP and increased risk of metastasis, either to lymph nodes or metastasis to other organs. There was no difference in survival time between the three different genotypes. The S-allele of the L-myc RFLP has been correlated to increased metastasis in lung cancer. We found no tendency towards a highe, frequency of this allele in the cohort of patients with positive family history compared to the patients with no known first degree relatives with cancer. A higher frequency of the S-allele in the adenocarcinomas compared to other histological groups was found, although this difference was not statistically significant. No difference in the gene frequency of the L-myc RFLP was found between the lung cancer patients and the normal controls. These results are in contrast with a previous report. Possible explanations for the discrepencies are discussed.
The myc family oncogenes are known to be involved in a variety of different cancers (Alt et al., 1986) . It is not known, however, where in the carcinogenesis the myc genes are involved, but some results indicate that amplification and rearrangements of myc genes occur during tumour progression and not in the initial steps (Bishop, 1987) . The myc genes restrain differentiation and are thought to be involved in proliferation.
The L-myc gene was initially identified by Nau et al. (1985) as a gene with structural similarity to c-myc and N-myc from a human SCLC cell line and was further characterised and sequenced by Kaye et al. (1988) . The gene was found to encode multiple DNA-binding phosphoproteins made from alternatively processed mRNAs (DeGreve et al., 1988) .
The expression of the L-myc gene is restricted to fetal brain, kidney and lung tissue and adult lung tissue, while the expression of the c-myc is more generalised (Zimmerman et al., 1986) . The expression of L-myc in both neonatal and adult lung is intriguing because the endocrine cells that give rise to small cell lung cancer (SCLC) are abundant in fetal lung and persist in reduced number in the adult lung.
The regulation of expression of the myc genes is complex (Krystal et al., 1988) . The L-myc gene seems to be regulated differently from the other myc genes (Saksela, 1987; DeGreve et al., 1988) .
In the search for genetic markers for cancer susceptibility as well as for diagnostic prognosis, restriction fragment length polymorphisms (RFLPs) of known oncogenes like L-myc, have been particularly considered. The influence of polymorphic variants of the human c-Haras gene on predisposition to lung cancer has also been investigated (Heighway et al., 1986; Rydberg et al., 1990) . A site polymorphism within the L-myc locus using the EcoRI enzyme has been described (Nau et al., 1985) . Three different genotypes (LL, LS, SS) consisting of two different alleles; L (large, 10kb) and S (small, 6kb) are seen. Kawashima et al. (1988) reported a correlation between this polymorphism of L-myc and the prognosis of lung cancer patients. Patients homozygote for the L-band had fewer lymph node metastatic lesions and less metastasis to other organs. Kawashima et al. (1988) proposed that this L-myc polymorphism could be a useful marker for predicting the metastatic potential of human lung cancer.
In a study of colorectal cancer Kawashima et al. (1987) found a correlation between increased metastasis and the S-allele of the L-myc EcoRI RFLP. A similar study by Ikeda et al. (1988) did not confirm these findings. Nor did they observe any specific allele association with colon cancer, as reported by Kawashima et al. (1987) . On the other hand, Kakehi and Yoshida (1989) Information about cancers in the family, smoking habits and possible occupational or other exposure to known lung carcinogens were obtained from the hospital files. In addition all patients available (n = 30) were interviewed about family history.
Tumour size and metastasis to lymph nodes and other organs were evaluated by computer tomography. Almost all the lung cancer cases were TNM classified according to the UICC guidelines (version 1989) . This was done by a trained clinician. The samples were collected before any chemotherapeutic or radiation therapy treatment had been started. The 129 controls were students and laboratory staff. Both the patients and the controls were Norwegian caucasians. All samples were stored at -40°C until isolation of DNA.
DNA isolation and Southern blot analysis of the L-myc gene DNA was isolated from the leukocytes in 20 ml EDTA blood by a method adopted from Kunkel et al. (1977) with the following modifications. Twenty ml EDTA blood was diluted with 30 ml cold buffer (0.32 M sucrose, 5 mM MgC12, 1% Triton X-100 and 0.01 M Tris-HCI, pH 7.6 at 25C), vortexed and centrifuged for 15min at 2,500g. The pellet was gently ground with a glass rod, resuspended in 50 ml of the same buffer, and centrifuged (3,500 g, 15 min).
The leukocyte pellet was suspended in 2 ml of 75 mM NaCI, 24mM NaEDTA, pH 8.0 and frozen for 20 min at -70C before addition of 7 ml of the same salt solution, 1 ml of 5% SDS and 50 mg ml' proteinase K. 
Results
The EcoRI digest of human genomic DNA contains two L-myc related fragments of 10 kb (large = L) and 6 kb (small = S) which have been shown by Nau et al. (1985) to be due to a polymorphic EcoRI site. A typical autoradiogram with the three genotypes is shown in Figure 1 . Table I shows the distribution of the three genotypes in the lung cancer patients compared to the control group. There are no significant differences in frequency of the L and S alleles in the two groups. The frequencies of the L and S alleles are 0.5 for both alleles in the control group, 0.48 for the L-allele and 0.52 for the S-allele for the lung cancer patients. This is similar to the gene frequencies found by Nau et al. (1985) when their results from tumour material and controls were pooled (166 alleles) (L = 0.51, S = 0.49). There was no correlation between the SS genotype and increased metastasis to distal organs or to lymph nodes as found by Kawashima et al. (1988) . On the contrary, there was a striking similarity of the distribution of the three genotypes among different stages. Kawashima et al. (1988) . No such correlation could be found in our population of 83 lung cancer patients, nor was there any difference in time of survival between the three different genotypes LL, LS and SS.
There are three possible explanations for this discrepancy: random variation, stratification and/or linkage disequilibrium. Firstly, the different results could be due to random variation prone to occur when the populations studied are relatively small. We did not find any differences in allele frequencies between the control and lung cancer population and both were similar to the frequencies published by Nau et al. (1985) . In the Japanese lung cancer population there was a higher frequency of the S-allele (L = 0.37, S = 0.67) compared to control (L = 0.43, S = 0.57, n = 20 (Fraumeni & Blot, 1982; IARC, 1986 ). An epidemiological study (Anton-Culver, 1988 ) also indicates that it could be due to differences in the aetiology of adenocarcinoma and other histological types, since the adenocarcinoma are diagnosed at a younger age than other types of lung cancer. Adenocarcinoma is also the most common type among women regardless of smoking habits. Squamous cell carcinoma is the most common histological type of lung cancer among men. An increased risk of adenocarcinoma linked to the SS allele could be consistent with our data. This has to be confirmed in a larger series of patients.
Secondly, the different results could be explained by stratification in the ascertainment of the patients in the Japanese, in the Norwegian or in both studies. There are some differences between the two lung cancer populations. All the Japanese lung cancer patients except for the small cell lung cancers underwent surgery. Tumour size and metastasis to local lymph nodes could then easily be determined at the time of operation. All our patients had advanced and inoperable disease and information about tumour size and lesion to lymph nodes was more difficult to obtain. In a cohort of lung cancer patients with advanced illness one could fail to detect the difference in metastasis if this polymorphism is linked to the speed of the metastasis process. On the other hand, if the presence of the S-allele is correlated to the metastatic process, a higher frequency of the S-allele would be expected in a population with advanced cancer compared to controls. This was not seen in our population.
A third explanation for the difference between Kawashimas and our results may be that L-myc is not important, but is linked to a gene which is involved in the metastatic process. Linkage disequilibrium may differ in genetic distant populations. Furthermore, the polymorphic EcoRI site is in the second intron outside the area transcribed and is not likely to be directly involved in the regulation of the gene expression or have any consequence for the amino acid sequence in the protein. Thus, Kawashima et al. (1988) may have described a node or metastasis-disposing haplotype in their population which we did not find. Kawashima et al. (1988) refer to unpublished results which show no correlation between increased metastasis and the S-allele when the typing was made one year or more after the initial diagnosis. Their explanation for this discrepancy is that the S-allele is associated with the speed and extent of metastasis and not to the incidence of metastasis. The similarity in the survival rate in the three genotypes in our patients support the hypothesis that there is no correlation between SS and LS genotype and metastasis. If there were any differences, either in the incidence or speed of metastasis between these three genotypes, a different time of survival would be expected. No such difference was found.
The results of our study therefore seem to demonstrate that RFLP typing of the L-myc has limited or no value as a prognostic marker in lung cancer, particularly for the nonadenocarcinomas in our population. 
